非布索坦有药吗？

Is there a generic version of (Febuxostat)? Yes, and the price is affordable and the effect is ideal. Let’s take a look below. Febuxostat (Febuxostat) is a drug approved in 2009 for the treatment of chronic hyperuricemia. Compared with the traditional treatment drug allopurinol, febuxostat (febuxostat) is more effective in reducing uric acid. The most common adverse reactions are abnormal liver function, diarrhea and rash. Medication guidelines recommend a starting dose of 40 mg/d. In patients with mild to moderate renal impairment (creatinine clearance [CrCl] 30-89 mL/min), the starting dose is the same as in patients with normal renal function.

The price of original medicine in Japan is higher than that in India, about 1,500$ per box. Febuxostat (Febuxostat) produced by Zydus Pharmaceutical Factory in India has the same efficacy as the original drug, but the price is indeed much lower. The specification is 80mg*30 tablets/box. Its price is about 200$. Due to the floating exchange rate, the price cannot be accurate. For specific prices, please consult the regular overseas medical service company Medical Travel.

Febuxostat (Febuxostat) was started at 10 mg/day for 2 weeks, then increased to 20 mg/day for 4 weeks, then to 40 mg/day. Starting with a low dose and gradually increasing the dose can prevent acute gout attacks caused by initial changes in blood uric acid levels. Treat with febuxostat (Febuxostat) 40 mg/day for 6 months, and review uric acid levels regularly. Generally, it takes 6 months to clean up excess blood uric acid in the body.

After 6 months of treatment:

(1) If the blood uric acid level remains between 240 umol/l and 360 umol/l, maintain treatment with febuxostat (febuxostat) 40 mg/day.

(2) If the blood uric acid level is higher than 360 umol/l, increase the dose of febuxostat to 60 mg/day, up to a maximum of 80 mg/day, and monitor blood uric acid, liver and kidney function regularly.

(3) If the blood uric acid level is lower than 240 umol/l, the dose of (febuxostat) can be reduced to 20 mg/day and the treatment can be maintained for 6 months.

Recommended related articles: